Trial
NCT00489710
Talabostat in Treating Patients With Metastatic Kidney Cancer
Phase IIWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
University of Nebraska
Collaborators
—
Condition
Kidney Cancer
Intervention
talabostat mesylate
Why stopped
safety reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-22